Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 8/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 5/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.44 |
| ▸ | CA12 | O43570 | 3/20 | 0.42 |
| ▸ | CA1 | P00915 | 3/20 | 0.42 |
| ▸ | CA2 | P00918 | 3/20 | 0.42 |
| ▸ | CA9 | Q16790 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | CDK1 | P06493 | 1/20 | 0.42 |
| ▸ | KDR | P35968 | 1/20 | 0.42 |
| ▸ | AR | P10275 | 1/20 | 0.41 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8095481 | 0.91 | PTGS2 (0.54) | CNR1PTGS2PTGS1KDM4EL3MBTL1 | |
| SCHEMBL8776744 | 0.91 | SQOR (0.46) | CNR1PTGS2PTGS1CA1CA2 | |
| SCHEMBL8094989 | 0.88 | PTGS2 (0.53) | CNR1PTGS2PTGS1CA12CA1 | |
| SCHEMBL8093429 | 0.87 | CNR1 (0.44) | CNR1PTGS2PTGS1CA12CA1 | |
| SCHEMBL8094551 | 0.87 | CNR1 (0.49) | CNR1PTGS2PTGS1CA12CA1 | |
| SCHEMBL8093195 | 0.86 | PTGS2 (0.47) | CNR1PTGS2PTGS1CA12CA1 | |
| SCHEMBL8093715 | 0.85 | CNR1 (0.46) | CNR1PTGS2PTGS1CA12CA1 | |
| SCHEMBL8094547 | 0.85 | PTGS2 (0.60) | CNR1PTGS2PTGS1CA12CA1 | |
| SCHEMBL8086461 | 0.84 | CNR1 (0.61) | CNR1PTGS2PTGS1CA12CA1 | |
| SCHEMBL8094093 | 0.84 | CNR1 (0.46) | CNR1PTGS2PTGS1CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0808304-B1 | 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION | SEARLE & CO (US) | 2000-12-27 | — | — | EP | disclosed |